WO2008146914A1 - 複素環化合物 - Google Patents
複素環化合物 Download PDFInfo
- Publication number
- WO2008146914A1 WO2008146914A1 PCT/JP2008/060028 JP2008060028W WO2008146914A1 WO 2008146914 A1 WO2008146914 A1 WO 2008146914A1 JP 2008060028 W JP2008060028 W JP 2008060028W WO 2008146914 A1 WO2008146914 A1 WO 2008146914A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- ring
- alkoxy
- useful
- heterocyclic group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
式 (式中、環Aはピリミジン等を示し、環Bは置換されていてもよい炭素環、置換されていてもよい芳香族複素環または置換されていてもよい脂環式複素環を示し、環Cは置換されていてもよい芳香族炭素環を示し、Xは単結合またはアルキレンを示し、R1は置換されていてもよい複素環式基または複素環式基置換アルコキシ等を示し、R2は水素、アルキル、ハロアルキル、アルコキシ、アルカノイル、シアノ、カルバモイル、アルコキシカルボニル、ハロゲン等を示し、mは1、2を示す。) で表される化合物またはその製薬上許容しうる塩は、気管支喘息、アトピー性皮膚炎等の疾患の予防・治療に有用なCCR4機能調節剤として有用である。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007147090A JP2010208945A (ja) | 2007-06-01 | 2007-06-01 | 複素環化合物 |
JP2007-147090 | 2007-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008146914A1 true WO2008146914A1 (ja) | 2008-12-04 |
Family
ID=40075144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/060028 WO2008146914A1 (ja) | 2007-06-01 | 2008-05-30 | 複素環化合物 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2010208945A (ja) |
WO (1) | WO2008146914A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011079114A1 (en) * | 2009-12-23 | 2011-06-30 | Elan Pharmaceuticals, Inc. | Pteridinones as inhibitors of polo - like kinase |
JP2013508328A (ja) * | 2009-10-21 | 2013-03-07 | エフ.ホフマン−ラ ロシュ アーゲー | ケモカイン受容体のモジュレーターとしてのジアゼパン誘導体 |
JP2015500240A (ja) * | 2011-12-01 | 2015-01-05 | ケモセントリックス,インコーポレイティド | Ccr(4)アンタゴニストとしての置換ベンズイミダゾール及びベンゾピラゾール |
US9045445B2 (en) | 2010-06-04 | 2015-06-02 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
CN104672147A (zh) * | 2015-02-17 | 2015-06-03 | 衢州学院 | 一种2,4-二羟基-5-嘧啶甲酸甲酯的制备方法 |
EP2473486B1 (de) | 2009-09-02 | 2015-10-28 | Vifor (International) Ag | Pyrimidine als hepcidin-antagonisten |
WO2019147862A1 (en) * | 2018-01-26 | 2019-08-01 | Flx Bio, Inc. | Chemokine receptor modulators and uses thereof |
JP2019525962A (ja) * | 2016-07-29 | 2019-09-12 | ラプト・セラピューティクス・インコーポレイテッド | ケモカイン受容体調節剤及びそれの使用 |
CN115043780A (zh) * | 2022-07-11 | 2022-09-13 | 上海飞琰化工科技有限公司 | 一种4-羟基-5-氟-6-乙基嘧啶的合成方法及其应用 |
EP3929198A4 (en) * | 2019-02-19 | 2022-11-16 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING IT, METHOD FOR PREPARING IT AND ITS USE |
WO2023143194A1 (zh) * | 2022-01-25 | 2023-08-03 | 瑞石生物医药有限公司 | 一种ccr4小分子拮抗剂及其用途 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA029054B1 (ru) | 2012-10-11 | 2018-02-28 | Саузерн Рисерч Инститьют | Мочевинные и амидные производные аминоалкилпиперазинов и их применение |
CA2896731A1 (en) * | 2012-12-28 | 2014-07-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011442A1 (ja) * | 2002-07-29 | 2004-02-05 | Shizuoka Coffein Co., Ltd. | ピリミジン誘導体 |
WO2004074260A1 (ja) * | 2003-02-21 | 2004-09-02 | Kyowa Hakko Kogyo Co., Ltd. | ピリミジン誘導体 |
WO2005082865A1 (ja) * | 2004-02-27 | 2005-09-09 | Astellas Pharma Inc. | 縮合二環性ピリミジン誘導体 |
WO2005085212A1 (ja) * | 2004-03-04 | 2005-09-15 | Astellas Pharma Inc. | 置換ピリミジン誘導体 |
WO2006004776A1 (en) * | 2004-06-29 | 2006-01-12 | Rigel Pharmaceuticals, Inc. | 4-pyrimidineamine compounds and their uses as anti-proliferative agents |
-
2007
- 2007-06-01 JP JP2007147090A patent/JP2010208945A/ja active Pending
-
2008
- 2008-05-30 WO PCT/JP2008/060028 patent/WO2008146914A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011442A1 (ja) * | 2002-07-29 | 2004-02-05 | Shizuoka Coffein Co., Ltd. | ピリミジン誘導体 |
WO2004074260A1 (ja) * | 2003-02-21 | 2004-09-02 | Kyowa Hakko Kogyo Co., Ltd. | ピリミジン誘導体 |
WO2005082865A1 (ja) * | 2004-02-27 | 2005-09-09 | Astellas Pharma Inc. | 縮合二環性ピリミジン誘導体 |
WO2005085212A1 (ja) * | 2004-03-04 | 2005-09-15 | Astellas Pharma Inc. | 置換ピリミジン誘導体 |
WO2006004776A1 (en) * | 2004-06-29 | 2006-01-12 | Rigel Pharmaceuticals, Inc. | 4-pyrimidineamine compounds and their uses as anti-proliferative agents |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2473486B1 (de) | 2009-09-02 | 2015-10-28 | Vifor (International) Ag | Pyrimidine als hepcidin-antagonisten |
JP2013508328A (ja) * | 2009-10-21 | 2013-03-07 | エフ.ホフマン−ラ ロシュ アーゲー | ケモカイン受容体のモジュレーターとしてのジアゼパン誘導体 |
WO2011079114A1 (en) * | 2009-12-23 | 2011-06-30 | Elan Pharmaceuticals, Inc. | Pteridinones as inhibitors of polo - like kinase |
WO2011079118A1 (en) * | 2009-12-23 | 2011-06-30 | Elan Pharmaceuticals, Inc | Pteridinones as inhibitors of polo-like kinase |
CN102762568A (zh) * | 2009-12-23 | 2012-10-31 | 伊兰药品公司 | 作为polo样激酶的抑制剂的蝶啶酮 |
JP2013515734A (ja) * | 2009-12-23 | 2013-05-09 | エラン ファーマシューティカルズ,インコーポレイテッド | ポロ様キナーゼの阻害薬としてのプテリジノン |
US8445503B2 (en) | 2009-12-23 | 2013-05-21 | Elan Pharmaceuticals, Inc. | Inhibitors of polo-like kinase |
US8541418B2 (en) | 2009-12-23 | 2013-09-24 | Elan Pharmaceutical, Inc. | Inhibitors of polo-like kinase |
US9045445B2 (en) | 2010-06-04 | 2015-06-02 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
JP2015500240A (ja) * | 2011-12-01 | 2015-01-05 | ケモセントリックス,インコーポレイティド | Ccr(4)アンタゴニストとしての置換ベンズイミダゾール及びベンゾピラゾール |
CN104672147A (zh) * | 2015-02-17 | 2015-06-03 | 衢州学院 | 一种2,4-二羟基-5-嘧啶甲酸甲酯的制备方法 |
JP2019525962A (ja) * | 2016-07-29 | 2019-09-12 | ラプト・セラピューティクス・インコーポレイテッド | ケモカイン受容体調節剤及びそれの使用 |
WO2019147862A1 (en) * | 2018-01-26 | 2019-08-01 | Flx Bio, Inc. | Chemokine receptor modulators and uses thereof |
US10683280B2 (en) | 2018-01-26 | 2020-06-16 | Rapt Therapeutics, Inc. | Chemokine receptor modulators and uses thereof |
CN111971279A (zh) * | 2018-01-26 | 2020-11-20 | 拉普特医疗公司 | 趋化因子受体调节剂及其用途 |
US11192879B2 (en) | 2018-01-26 | 2021-12-07 | Rapt Therapeutics, Inc. | Chemokine receptor modulators and uses thereof |
US11384064B2 (en) | 2018-01-26 | 2022-07-12 | Rapt Therapeutics, Inc. | Chemokine receptor modulators and uses thereof |
AU2019212478B2 (en) * | 2018-01-26 | 2023-02-23 | Rapt Therapeutics, Inc. | Chemokine receptor modulators and uses thereof |
AU2019212478C1 (en) * | 2018-01-26 | 2023-11-16 | Rapt Therapeutics, Inc. | Chemokine receptor modulators and uses thereof |
TWI826416B (zh) * | 2018-01-26 | 2023-12-21 | 美商瑞佩特治療公司 | 趨化介素受體調節劑及其用途 |
EP3929198A4 (en) * | 2019-02-19 | 2022-11-16 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING IT, METHOD FOR PREPARING IT AND ITS USE |
WO2023143194A1 (zh) * | 2022-01-25 | 2023-08-03 | 瑞石生物医药有限公司 | 一种ccr4小分子拮抗剂及其用途 |
CN115043780A (zh) * | 2022-07-11 | 2022-09-13 | 上海飞琰化工科技有限公司 | 一种4-羟基-5-氟-6-乙基嘧啶的合成方法及其应用 |
CN115043780B (zh) * | 2022-07-11 | 2024-01-16 | 上海飞琰化工科技有限公司 | 一种4-羟基-5-氟-6-乙基嘧啶的合成方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
JP2010208945A (ja) | 2010-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008146914A1 (ja) | 複素環化合物 | |
WO2008062905A3 (en) | Heteromonocyclic compound and use thereof | |
WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
WO2009079008A8 (en) | Benzopyrans and analogs as rho kinase inhibitors | |
MY150507A (en) | Polycyclic compound | |
WO2008005368A3 (en) | Piperazines as p2x7 antagonists | |
WO2008057775A3 (en) | Heterocyclic amide compounds useful as kinase inhibitors | |
WO2006030977A3 (en) | Imidazole derivatives as large conductance calcium-activated k channel openers | |
WO2005103037A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
AU2008255733A8 (en) | Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity | |
TNSN08407A1 (en) | Organic compounds | |
WO2009065919A3 (de) | Organische verbindungen | |
WO2007061923A3 (en) | Glucokinase activators | |
WO2008146665A1 (ja) | 有機エレクトロルミネッセンス素子用材料及び有機エレクトロルミネッセンス素子並びに有機エレクトロルミネッセンス表示装置 | |
TW200612958A (en) | Substituted imidazole derivatives | |
WO2009065920A3 (de) | Verbindungen | |
WO2009019015A8 (en) | Novel herbicides | |
WO2007000339A8 (en) | Bicyclic derivatives as p38 kinase inhibitors | |
EP1867331A4 (en) | TRIAZOL DERIVATIVE AND ITS USE | |
EP1726584A4 (en) | 2-AMINOCHINAZOLINDERIVAT | |
WO2008140066A3 (en) | Pyridone derivatives as p38a mapk inhibitors | |
WO2009057784A1 (ja) | 複素環化合物 | |
WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
WO2008086122A3 (en) | Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) | |
GEP20125637B (en) | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08777039 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08777039 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |